Health ❯ Healthcare ❯ Pharmaceuticals

Medications

GLP-1 Drugs GLP-1 Receptor Agonists Weight Loss Semaglutide Weight Loss Drugs Alzheimer's Disease Tirzepatide Statins Weight Loss Treatments Wegovy

New Study Finds Nearly Fivefold Higher Reported ‘Eye Stroke’ Risk With Wegovy vs Ozempic

A retrospective FDA adverse‑event analysis reported the signal, prompting regulator warnings and calls for prospective studies.

France’s First In-Utero Treatment Shrinks Fetal Vascular Tumor, Baby Avoids Intubation

Democratic Report Puts TrumpRx Under Fresh Scrutiny as Analyses Question Real-World Savings

Brazil Government Opposes Patent Breaks for Weight-Loss Pens After House Fast-Tracks Bill

Major Lancet Analysis Finds Most Statin Label Side Effects Not Caused by the Drugs

Major Lancet Meta-Analysis Finds Statins Don’t Cause Most Listed Side Effects

Anvisa Expands Wegovy and Ozempic Uses to Cardiovascular and Kidney Protection

UK Regulator Flags Rare Pancreatitis, Including Deaths, Tied to Wegovy and Mounjaro

Russia Approves Adult Influenza Care Standard and Publishes Official Drug List

Wegovy Pill Posts Strong U.S. Debut as U.K. Authorizes Higher 7.2 mg Injectable Dose

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

RPS Warns Over Nasal Spray Overuse, Citing Rebound Congestion After Seven Days

Brazil Authorizes Leqembi for Early-Stage Alzheimer’s Treatment

RPS Warns Users to Limit Nasal Decongestant Sprays to Seven Days

FDA Approves First Wegovy Pill for Chronic Weight Management

Laís Caldas’ Pregnancy Renews Warnings on Mounjaro’s Effect on Oral Contraceptives

Brazil Cracks Down on Illicit Mounjaro Sales as Lilly Launches QR Verification Tool

Argentina Launches Lilly’s Mounjaro for Obesity and Diabetes After ANMAT Approval

Yahoo Finance Highlights Merck and Bristol Myers as Value Plays Outside the GLP-1 Surge

Health Ministry Sends Emergency Tacrolimus Batch to EsSalud, Two More Set This Week